Robbins Farley’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Robbins Farley’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,054	Closed	-$1.97M	–	179
2024 Q1	$1.97M	Buy	6,054 +1,512	+33%	+$371K	1.04%	41
2023 Q4	$866K	Buy	4,542 +45	+1%	+$8.51K	0.52%	55
2023 Q3	$895K	Buy	4,497 +306	+7%	+$72.4K	0.6%	54
2023 Q2	$1.2M	Buy	4,191 +1,584	+61%	+$440K	0.83%	50
2023 Q1	$565K	Buy	2,607 +162	+7%	+$31.6K	0.38%	53
2022 Q4	$503K	Buy	+2,445	New	+$618K	0.39%	49
2022 Q1	–	Sell	-25	Closed	-$4K	–	192
2021 Q4	$4K	Buy	+25	New	+$4.93K	﹤0.01%	130

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Robbins Farley's SWAV Position: Q2 2024 in Review

Robbins Farley sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 6,054 shares — an estimated $1.97M sold.

Robbins Farley first reported a position in SWAV in Q4 2021 and held it in 7 quarters. The position peaked at $1.97M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Robbins Farley reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Robbins Farley sold 6,054 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.97M.
Robbins Farley first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Robbins Farley's Shockwave Medical, Inc. Common Stock position peaked at $1.97M in Q1 2024.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Robbins Farley's 13F filing for Q2 2024, filed 17 Jul 2024.